3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Neutropenia
1
Neoplasms
1
Hematologic Neoplasms
1
Fever
1
Febrile Neutropenia
1
Interventions
Filgrastim
7
pegylated granulocyte colony-stimulating factor
5
pegfilgrastim
5
Cytarabine
4
Ciprofloxacin
4
Cefepime
4
Vancomycin
3
Leucovorin
3
Fluorouracil
3
Amikacin
3
trifluridine tipiracil drug combination
2
Piperacillin, Tazobactam Drug Combination
2
Methylprednisolone
2
Meropenem
2
Irinotecan
2
Etoposide
2
Daptomycin
2
Cisplatin
2
Ceftazidime
2
ziprasidone
1
trilaciclib
1
sargramostim
1
niraparib
1
liposomal amphotericin B
1
lintuzumab
1
leridistim
1
isavuconazole
1
fludarabine phosphate
1
flt3 ligand protein
1
fish oil triglycerides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neutropenia
×
Cilastatin, Imipenem Drug Combination
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled